Dr. Reddy's Laboratories Ltd. 500124 shares shed 1.29% to 1,339.35 Indian rupees Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the BSE SENSEX Index ...

Stay updated with the Dr Reddys Stock Liveblog, your one-stop destination for real-time information and analysis of a leading ...

Analysts have mixed stances after the pharma firm's earnings. Check out what they have suggested. Dr Reddy's Labs reported ...

Dr. Reddy's Laboratories Limited (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as "Dr. Reddy's") announced that its Annual Report in Form 20 ...

Dr. Reddy's Laboratories Ltd. 500124 shares slid 1.41% to 1,356.85 Indian rupees Tuesday, on what proved to be an all-around rough trading session for the stock market, with the BSE SENSEX Index 1 ...

Dr Reddy’s Laboratories said the USFDA has completed a Pre-License Inspection at its biologics manufacturing facility in ...

Add Yahoo as a preferred source to see more of our stories on Google. SHREVEPORT, La. (KTAL/KMSS) – Dr. Reddy’s Laboratories, a global pharmaceutical company, recently closed in early 2025 due to ...

Get Dr Reddy’s Laboratories News on Telangana Today, Dr Reddy’s Laboratories latest news, Dr Reddy’s Laboratories news, | Telangana Today ...

Dr Reddy's Laboratories shares extended their gaining streak to the seventh consecutive session on Monday, emerging among the top performers on the Nifty50 index. The stock gained after the US drug ...

Dr. Reddy’s Chairman emphasizes the urgent need for stronger translational research to drive innovation in Indian pharma for ...

Get Dr Reddys Laboratories latest Profit & Loss account, Income Statement, Financial Statements and Dr Reddys Laboratories detailed profit and loss accounts including income, expenses, and net profit.

India must shift from minor advancements to large-scale innovation to become a global discovery hub, according to Dr. Reddy's ...